Form3 Successfully Completes $60M Series C Extension, With New Investment From British Patient Capital and Existing Shareholders

Form3, the cloud-native account-to-account platform, today announces a new investor, British Patient Capital. Alongside existing strategic and financial investors including Visa, Form3 has now raised a total of $60m in C-series extension funding to continue its growth journey. This funding will enable Form3 to develop new products and services to help support exponential growth in key markets such as the UK, Europe and the US. Benyam Hagos, Chief Financial Officer, Form3 says: “British Patient Capital’s investment enables Form3 to continue to deliver mission-critical infrastructure technology for the world’s most established banks and financial institutions.” Today’s funding announcement follows Visa’s recent investment in Form3 and its cloud-native account-to-account platform. Form3’s vision for the future of next-generation payments infrastructure is supported by major strategic players, including Visa. Tom Haywood, Managing Director, Direct Investments, British Patient Capital, said: “Form3 has built a leading solution for a challenge that banks worldwide are facing: how to transition to a modern, future-proof payments infrastructure. We are delighted to support them as they take the next steps in their growth journey”.